Cargando…

Treatment of distant metastases from follicular cell-derived thyroid cancer

Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration at suppressive doses, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of (131)I in their metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlumberger, Martin, Leboulleux, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335791/
https://www.ncbi.nlm.nih.gov/pubmed/25750740
http://dx.doi.org/10.12703/P7-22
_version_ 1782358398171348992
author Schlumberger, Martin
Leboulleux, Sophie
author_facet Schlumberger, Martin
Leboulleux, Sophie
author_sort Schlumberger, Martin
collection PubMed
description Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration at suppressive doses, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of (131)I in their metastases. Two thirds of distant metastases will become refractory to radioiodine at some point, and when there is a significant tumor burden and documented progression on imaging, a treatment with a kinase inhibitor may provide benefits.
format Online
Article
Text
id pubmed-4335791
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-43357912015-03-06 Treatment of distant metastases from follicular cell-derived thyroid cancer Schlumberger, Martin Leboulleux, Sophie F1000Prime Rep Review Article Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration at suppressive doses, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of (131)I in their metastases. Two thirds of distant metastases will become refractory to radioiodine at some point, and when there is a significant tumor burden and documented progression on imaging, a treatment with a kinase inhibitor may provide benefits. Faculty of 1000 Ltd 2015-02-03 /pmc/articles/PMC4335791/ /pubmed/25750740 http://dx.doi.org/10.12703/P7-22 Text en © 2015 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Schlumberger, Martin
Leboulleux, Sophie
Treatment of distant metastases from follicular cell-derived thyroid cancer
title Treatment of distant metastases from follicular cell-derived thyroid cancer
title_full Treatment of distant metastases from follicular cell-derived thyroid cancer
title_fullStr Treatment of distant metastases from follicular cell-derived thyroid cancer
title_full_unstemmed Treatment of distant metastases from follicular cell-derived thyroid cancer
title_short Treatment of distant metastases from follicular cell-derived thyroid cancer
title_sort treatment of distant metastases from follicular cell-derived thyroid cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335791/
https://www.ncbi.nlm.nih.gov/pubmed/25750740
http://dx.doi.org/10.12703/P7-22
work_keys_str_mv AT schlumbergermartin treatmentofdistantmetastasesfromfollicularcellderivedthyroidcancer
AT leboulleuxsophie treatmentofdistantmetastasesfromfollicularcellderivedthyroidcancer